CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more confident decision-making, today announced the full scientific program for the 2026 'From Insight to Decision' e-Symposium.
Read original article on The Medical News →Related news
-
Same calories, different responses: Food processing influences metabolism and brain activity
United Kingdom
-
ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove
United Kingdom
-
Dr. GPCR and Eurofins Discovery join forces to advance GPCR drug discovery
United Kingdom
-
Meet the 14-year-old uncovering London’s lost history
United Kingdom
-
Good News in History, October 5
United Kingdom
-
MedPharm inks deal to support global pharmaceutical company with commercial site transfer
United Kingdom
-
Ending clock changes? Health evidence favors permanent standard time over daylight saving
United Kingdom
-
Black people at higher risk of severe complications during pregnancy, labor, and the postpartum period
United Kingdom